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Purpose: An increase of matrix metalloproteinase-2 (MMP-2) has been found to improve outflow through the uveoscleral
pathway. This experiment was designed to test whether reduction of inhibitor of nuclear factor kappa B alpha (IκBα)
levels could enhance MMP-2 expression in human ciliary muscle (HCM) cells in vitro.
Methods: The small interfering RNA (siRNA) targeting inhibitor of nuclear factor kappa B (IκBα) was transfected into
HCM cells. The mRNA and protein levels of IκBα, nuclear factor-kappa B (NF-κB)p65, MMP-2, tissue inhibitor of
metalloproteinase-2 (TIMP-2), and membrane-type 1 matrix metalloproteinase (MT1-MMP) in HCM cells were examined
24 h, 48 h, and 72 h after IκBα siRNA transfection by real-time reverse transcription polymerase chain reaction (RT–PCR)
and western blot. The activation of NF-κBp65 was determined through the translocation of NF-κBp65 by fluorescence
microscope. Gelatin zymography was used to detect the secretion and activity of MMP-2.
Results: Real-time RT–PCR and western blot showed that transfection of IκBα siRNA led to gradual downregulation of
IκBα and TIMP-2 both at the mRNA and protein level after 24 h, 48 h and 72 h. The IκBα and TIMP-2 mRNA levels
decreased 92.7%±1.6% and 70.3%±13.1%, respectively, and the protein levels were reduced 87.3%±2.0% and 62.9%
±0.8% (p<0.01), respectively, when compared to the control 72 h after siRNA transfection. Conversely, the MMP-2 and
MT1-MMP mRNA and protein levels increased in the time-dependent manner after IκBα siRNA transfection. The MMP-2
and MT1-MMP mRNA levels increased 178%±4.6% and 165%±8.2%, respectively, while protein levels were raised to
162%±3.7% and 157.6%±5.7% (p<0.01), respectively, when compared to the control 72 h after IκBα siRNA transfection.
Although no obvious changes were seen in either mRNA or protein levels of total NF-κBp65 (p>0.05), the protein level
of NF-κBp65 increased dramatically in the nucleus as revealed by western blot and fluorescence staining 24 h, 48 h, and
72 h after IκBα siRNA transfection. Moreover, gelatin zymography indicated that the secretion and activity of MMP-2 in
treated cells were higher than those in the control cells. The maximum increases of pro-MMP-2 and active-MMP-2 were
172%±15% and 151%±14% (p<0.01), respectively, when compared to the control at the experiment’s conclusion 72 h
after siRNA transfection.
Conclusions: Expression and activity of MMP-2 was enhanced by the IκBα siRNA in HCM cells through the activation
of the NF-κB signaling pathway. Our results suggested that IκBα may therefore be a potential target for controlling the
uveoscleral outflow pathway in glaucoma.
In  glaucomatous  primates  [1]  and  humans  [2],
prostaglandin  (PG)F2α  has  been  shown  to  lower  the
intraocular  pressure  (IOP),  which  results  from  increased
uveoscleral  outflow.  Although  the  precise  mechanism  by
which prostaglandins improve uveoscleral outflow is not fully
understood, two possible mechanisms that have been studied
are  relaxation  of  the  ciliary  muscle  and  remodeling  the
extracellular matrix of the ciliary muscle [3,4]. Researchers
have attributed the increase in uveoscleral outflow to a group
of enzymes named matrix metalloproteinases (MMPs) [5,6].
MMPs are zinc-dependent endopeptidases that play a key
role in regulating the modulations of the extracellular matrix
Correspondence to: Jian Ge, M.D., Ph.D., Department of Glaucoma,
Zhongshan Ophthalmic Center, Sun Yat-sen University, Xianlienan
Road 54, Guangzhou, Guangdong, China; Phone: 86-20-87331374;
FAX: 86-20-87333271; email: gejian@mail.sysu.edu.cn
(ECM). These molecules are secreted much like proenzymes
and become activated by proteolytic cleavage truncation [7].
MMP-2, a member of the family of MMPs, has been shown
to have proteinase activity in the degradation of multiple ECM
proteins such as type I collagen, laminin, fibronectin, and
several proteoglycans [8,9]. MMP-2 is secreted as an inactive
proenzyme,  pro-MMP-2.  The  activation  of  pro-MMP-2
requires  its  cell  surface  localization  and  cleavage  by  cell
membrane-type  1  matrix  metalloproteinase  (MT1-MMP),
which  controls  a  variety  of  physiologic  and  pathological
processes through the proteolytic degradation of extracellular
or  transmembrane  proteins  [10].  Tissue  inhibitor  of
metalloproteinase-2  (TIMP-2),  the  specific  inhibitor  of
MMP-2, is also involved in this process by forming a receptor
for  pro-MMP-2  [11].  It  has  been  confirmed  that  the
extracellular spaces separating ciliary muscle fibers of the
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1977uveoscleral outflow pathway contain abundant ECM [12,13].
Thus,  increased  degradation  of  ciliary  muscle  ECM  by
MMP-2 could remodel the ECM among the ciliary muscle
bundles and decrease the hydraulic resistance to uveoscleral
flow [14].
Nuclear  factor-kappa  B  (NF-κB)  is  one  of  the  major
transcription  factors  that  plays  a  critical  role  in  the  gene
regulation  of  multiple  cellular  processes  such  as
inflammation,  immune  responses,  cell  proliferation,  and
apoptosis [15,16]. Five members were identified among the
NF-κB  family  of  transcription  factors:  v-rel
reticuloendotheliosis viral oncogene homolog (Rel)A (p65),
RelB,  NF-κB1  (p50/p105),  NF-κB2(p52/p100),  and  c-Rel
[17]. In most cells, NF-κB forms various homodimers as well
as heterodimers, mainly between the p65 and p50 proteins.
The NF-κB dimers can form complexes in the cytoplasm with
the inhibitor of nuclear factor kappa B alpha (IκBα), which
masks the NF-κB nuclear localization sequence and results in
latent inactivity. However, upon activation by extracellular
stimuli  or  other  transcriptional  factors,  IκBα  is
phosphorylated  and  degraded  while  NF-κB  rapidly
translocates to the nucleus where it activates the transcription
expression of several important genes [18,19].
Several studies have documented that the suppression of
IκBα  could  induce  NF-κB  nuclear  translocation  and
consequently promote the increase of MMP-2 in several types
of human cells including Ewing sarcoma EW7 cells [20],
human  skin  cells  [21],  murine  melanoma  cells  [22],  and
HT1080 (fibrosarcoma) cells [23]. However, the molecular
mechanism  of  inducing  the  secretion  and  activation  of
MMP-2 in human ciliary muscle (HCM) cells still remains
unclear. This question has led us to investigate whether the
IκB/NF-κB signaling pathway influences MMP-2 expression
in HCM cells in vitro.
METHODS
Primary  HCM  cells:  Normal  primary  HCM  cells  were
established  and  cultured  as  described  previously  by  the
Declaration of Helsinki [24]. HCM cells were prepared from
eight donors with no history of eye diseases (five males, three
females) around 18–24 h after death and were obtained from
Zhongshan  Ophthalmic  Center  (Sun  Yat-sen  University,
Guangzhou, China) using a procedure described earlier [25].
The cells used in the present experiments were passaged four
to six times to minimize the dedifferentiation that might occur
in late passage. The HCM cells were further identified with
monoclonal  rabbit  anti-smooth  muscle  α-actin  and
monoclonal rabbit anti-Desmin (Sigma, St. Louis, MO) by
immunocytochemical staining.
Fluorescence immunostaining: HCM cells were grown on
coverslips in six-well plates. After 24 h, the cells were washed
three times with PBS, fixed with 4% formaldehyde, blocked
in fresh 1% BSA/PBS for 1 h, and stained with monoclonal
anti-smooth muscle α-actin (1:100; Sigma) and rhodamine-
conjugated goat anti-rabbit IgG (1:50; Sigma). The nuclei of
the  cells  were  counterstained  with  4',6'-diamidino-2-
phenylindole  dihydrochloride  (DAPI,  1:1000;  Sigma).
Control  cells  were  performed  using  PBS  instead  of  the
primary  antibody.  Stained  cells  were  viewed  with  the
Axioplan2 fluorescence microscope (Carl Zeiss, Oberkochen,
Germany). HCM cells were stained with monoclonal rabbit
anti-NF-κBp65 (1:50; BD, Franklin Lakes, NJ) and FITC-
conjugated goat anti-rabbit IgG (1:500; BD) by the procedure
described  above  24  h,  48  h,  and  72  h  after  IκBα  small
interfering  RNA  (siRNA)  transfection.  HCM  cells  were
stained with monoclonal rabbit anti-Desmin (1:100) and goat
anti-rabbit IgG (1:50) according to the instructions included
with  the  SP-9001  Histostain-Plus  Kit  (Beijing  Zhongshan
Gold Bridge, Beijing, China).
Preparation and transfection of siRNA: The siRNA sequences
used  for  silencing  IκBα  (GenBank  NM_020529)  were
designed, and Cy3-labled IκBα siRNA was synthesized by
Guangzhou Ribobio (Guangzhou, China).The sequences of
siRNAs were as follows: sense, 5′-CUC CGA GAC UUU
CGA GGA A dTdT-3′; antisense, 5′-UUC CUC GAA AGU
CUC GG AG dTdT-3′. For nonsense control siRNA, we used
irrelevant siRNA with random nucleotides and no known
specificity (Qiagen, Hilden, Germany). Its sequences were as
follows:  sense,  5′-UUC  UCC  GAA  CGU  GUC  ACG
UdTdT-3′; antisense, 5′-ACG UGA CAC GUU CGG AG A
AdTdT-3′. HCM cells (3×104) were plated in a six-well plate,
incubated  for  24  h,  and  transfected  with  a  IκBα-specific
siRNA duplex (50 nM final concentration) or the nonsense
control siRNA (50 nM) using the Lipofectamine 2000 reagent
(Invitrogen, Carlsbad, CA) according to the manufacturer’s
instructions.
Transfection  efficiency  of  siRNA:  To  monitor  transfection
efficiency, the HCM cells were transfected with Cy3-labled
IκBα siRNA in a six-well plate. The cells were washed twice
with PBS 24 h, 48 h, and 72 h after IκBα siRNA transfection
and then viewed by the Axioplan2 fluorescence microscope
(Carl  Zeiss).  Transfection  efficiency  was  determined  by
counting the fraction of fluorescing cells in 10 fields of view.
Real-time reverse transcription polymerase chain reaction
analysis: Total RNA was extracted from HCM cells with an
RNeasy kit (Qiagen, Hilden, Germany) 24 h, 48 h, and 72 h
after  IκBα  siRNA  transfection.  The  extracted  RNA  was
pretreated with RNAase-free DNase, and 0.2 μg of RNA from
each  sample  was  used  for  cDNA  synthesis  primed  with
random  hexamers.  Real-time  reverse  transcription
polymerase chain reaction (RT–PCR) was performed on six
genes, NF-κBp65, IκBα, MMP-2, TIMP-2, MT1-MMP, and
GAPDH (internal control). The real-time RT–PCR primers
are  summarized  in  Table  1.  Real-time  RT–PCR  was
performed in a total volume of 20 μl from a mixture containing
10 μl of SYBR1 Premix Ex Taq (Takara, Tokyo, Japan), 0.4
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1978μl  of  forward  primer  (10  mM),  0.4  μl  of  reverse  primer
(10 mM), 0.4 μl of ROX Reference Dye (50×; Takara, Tokyo,
Japan), 6.8 μl of dH2O, and 2 μl of template cDNA solution.
Reactions were run in an ABI PRISM7000 Sequence Detector
system  (Applied  Biosystems,  Foster  City,  CA)  under  the
following conditions: the PCR was run for 40 cycles of 95 °C
for 5 s, 56 °C for 15 s and 72 °C for 31s after pre-incubation
at 95°C for 10 s. All reactions were performed in duplicate.
The specificity of the amplification reactions was confirmed
by melting-curve analysis. Relative mRNA expression levels
of the six genes in the siRNA-treated samples and controls
were determined using the comparative threshold (Ct) method
and analyzed with Sequence Detector software version 1.7
(Applied  Biosystems).  The  fold  changes  in  the  mRNA
expression level of IκBα, NF-κBp65, MMP-2, TIMP-2, and
MT1-MMP  in  siRNA-treated  and  control  samples  were
compared using the 2-ΔΔCt method [26].
Western blot analysis: Total subcellular and nuclear proteins
in different groups were extracted by the Nuclear Extract Kit
(Active Motif, Carlsbad, CA) 24 h, 48 h, and 72 h after IκBα
siRNA  transfection,  according  to  the  manufacturer’s
instructions. Briefly, cells were scraped, washed in PBS, and
centrifuged for 5 min at 700× g at 4 °C. The supernatant was
discarded, and cells were resuspended in a hypotonic buffer
and incubated for 15 min on ice. Detergent was added and the
suspension  vortexed  for  10  s.  Next,  the  suspension  was
centrifuged for 30 s at 14,000× g, and the nuclear pellet was
resuspended in 50 μl of complete lysis buffer. The suspension
was incubated for 30 min on ice on a rocking platform set at
140× g and centrifuged for 10 min at 14,000× g at 4 °C. The
supernatant  was  used  as  nuclear  extract.  The  protein
concentration was measured by the Bio-Rad protein assay
(Bio-Rad, Hercules, CA). The total protein extracts (30 μg
each)  were  separated  from  each  sample  by  10%  sodium
dodecyl  sulfate  polyacrylamide  gel  electrophoresis  (SDS–
PAGE) and transferred onto poly vinylidene fluoride (PVDF)
membranes. The membranes were blocked with 5% blocking
reagent  at  room  temperature  for  1.5  h  and  probed  with
polyclonal  rabbit  anti-IκBα  (1:1,000;  Cell  Signaling
Technology,  Danvers,  MA),  polyclonal  rabbit  anti-MT1-
MMP (1:1,000; Santa Cruz Biotechnology, Santa Cruz, CA),
and polyclonal rabbit anti-GAPDH (1:5,000; BD) overnight
at 4 °C. The membranes were washed three times with the
blocking  buffer  and  incubated  with  goat  anti-rabbit  IgG
conjugated  with  horseradish  peroxidase  (HRP;  BD).  The
bands were visualized with an enhanced chemiluminescence
kit (ECL kit; Cell Signaling Technology). The protein level
of NF-κBp65 in both the total (30 μg) and nuclear (30 μg)
extracts  was  detected  by  western  blot  analysis  using
polyclonal  rabbit  anti-NF-κBp65  (1:1,000;  Cell  Signaling
Technology). MMP-2 and TIMP-2 expression was examined
as follows: the medium was replaced with serum-free growth
medium after transfection for 6 h. The conditioned medium
was  then  collected  and  concentrated  by  centrifugal
ultrafiltration (Amicon, Houston, TX) 24 h, 48 h, and 72 h
after IκBα siRNA transfection and stored at −80 °C. An equal
amount (30 μg) of total proteins was concentrated from the
medium to detect the expression of MMP-2 and TIMP-2 with
polyclonal  rabbit  anti-MMP-2  (1:1,000;  Cell  Signaling
Technology)  and  polyclonal  rabbit  anti-TIMP-2  (1:1,000;
Santa  Cruz  Biotechnology)  according  to  the  procedures
described above. The band intensities were quantified by Gel-
pro Analyzer 4.0 (Media Cybernetics, Silver Spring, MD).
Gelatin zymography analysis: The conditioned medium was
collected by centrifugation and concentrated 24 h, 48 h, and
72 h after IκBα siRNA transfection. Protein concentrations
were measured using the Bio-Rad protein assay. The samples
containing an equal amount of total proteins (30 μg) were
TABLE 1. NUCLEOTIDE SEQUENCES OF HUMAN SPECIFIC PRIMERS FOR REAL-TIME RT–PCR.
Gene Primers Sequence Product size
(bp)
IκBα Forward 5′-AAGTGATCCGCCAGGTGAAG-3′ 86
  Reverse 5′-GCAATTTCTGGCTGGTTGGT-3
NF-κBp65 Forward 5′-TCTCCCTGGTCACCAAGGAC-3′ 64
  Reverse 5′-TCATAGAAGCCATCCCGGC-3′
MMP-2 Forward 5′-CGAATCCATGATGGAGAGGC-3′ 87
  Reverse 5′-TCCGTCCTTACCGTCAAAGG-3
GAPDH Forward 5′-CACCAACTGCTTAGCACCCC-3′ 81
  Reverse 5′-TCTTCTGGGTGGCAGTGATG-3′
TIMP-2 Forward 5′-TTCATTCGTCTCCCGTCTTT-3′ 113
  Reverse 5′-ACCAACGTGTGTGGATCAAA-3′
MT1-MMP Forward 5′-TCGGCCCAAAGCAGCAGCTC-3 180
  Reverse 5′-CTTCATGGTGTCTGCATCAGC-3′
The oligonucleotide sequences of real-time RT-PCR primers for Human IκBα, NF-κBp65, MMP-2, GAPDH, TIMP-2, and
MT1-MMP are shown in the table.
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1979mixed with sample buffer in the absence of a reducing agent,
incubated at room temperature for 30 min, and loaded onto
10%  SDS–PAGE  containing  0.1%  gelatin  (Amersco,  St.
Louis, MO). After electrophoresis, gels were washed twice in
50  mM  Tris-HCl  buffer  (pH  7.5),  which  contained  2.5%
Triton  X-100,  for  30  min  followed  by  incubation  in  an
activation buffer (50 mM Tris-HCl [pH 7.5], 200 nM NaCl, 1
μM ZnCl2, and 10 mM CaCl2) for 24 h at 37 °C until enzymatic
degradation of the substrate took place. Gels were stained with
0.1% Coomassie blue R-250 (Sigma, St. Louis, MO) and then
destained. Gelatinolytic bands were observed as clear zones
against the blue background, and the intensity of the bands
was quantified by Gel-pro Analyzer 4.0 (Media Cybernetics)
to provide a semi-quantitative assay of the enzymatic activity.
Statistical  analysis:  All  results  were  presented  as  mean
±standard  deviation  (SD).  Statistical  significance  was
assessed with one-way analysis of variance (ANOVA). A
p<0.05 was considered statistically significant.
RESULTS
Establishment  of  primary  HCM  cells:  HCM  cells  were
prepared from normal human donors with no history of ocular
diseases. It takes about four to eight days for the primary HCM
cells  to  form  a  monolayer  of  spindle-shaped  cells  with
characteristic  “hill-and-valley  patterns”  [27,28].The  HCM
cells were identified by the positive staining of smooth muscle
α-actin and Desmin by immunocytochemistry (Figure 1A,C).
Negative control cultures showed no positive staining (Figure
1B,D), demonstrating that the cells we isolated were pure
HCM cells.
Transfection  efficiency  of  IκBα  siRNA:  Transfection
efficiency of IκBα siRNA 24 h, 48 h, and 72h after transfection
(determined by fluorescence microscopy) was 92%, 90%, and
91%, respectively (Figure 2A-C).
Suppression of IκBα mRNA and protein expression by siRNA
in HCM cells: We hypothesized that the IκBα pathway plays
a role in MMP-2 expression in HCM cells. Real-time RT–
PCR analysis was performed to examine the IκBα mRNA
level after specific IκBα siRNA transfection at 24 h, 48 h, and
72  h.  As  shown  in  Figure  3A,  IκBα  mRNA  levels  were
markedly suppressed at each time point to 41.1%±8.3% at 24
h, 78.7%±4.8% at 48 h, and 92.7%±1.6% (mean±SD, n=4) at
72 h, respectively, compared to those in control after IκBα
siRNA transfection. Furthermore, the western blot analysis
Figure 1. Identification of HCM cells.
The  third  passaged  HCM  cells  were
washed  with  PBS,  fixed  with
formaldehyde, blocked in BSA/PBS and
stained  with  monoclonal  anti-smooth
muscle  α-actin  and  rhodamine-
conjugated  goat  anti-rabbit  IgG;HCM
cells were also stained with monoclonal
rabbit anti-Desmin and goat anti-rabbit
IgG. HCM cells labeled with antibody
to smooth muscle actin (A; red) and the
negative  control  (B).  Nuclei  staining
with DAPI is shown in blue. HCM cells
labeled with antibody to desmin (Buffy;
C) and the negative control (D).
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1980indicated  dramatic  reduction  of  IκBα  protein  in  the  IκBα
siRNA-treated  cells  in  a  time  dependent  manner,  and  the
IκBα protein levels were suppressed significantly to 69.8%
±1.3% at 24 h, 83.1±1.6% at 48 h, and 87.3%±2.0% (mean
±SD, n=3) at 72 h, respectively, compared to those in control
after IκBα siRNA transfection (Figure 3B). Taken together,
these results indicated that IκBα mRNA and protein were
effectively repressed by IκBα siRNA in cultured HCM cells.
Effects of IκBα siRNA on MMP-2 expression in HCM cells:
In addition to studying IκBα level, we also analyzed MMP-2
expression  in  HCM  cells.  To  investigate  whether  the
knockdown of IκBα can upregulate MMP-2, the mRNA level
of MMP-2 was examined by real time RT–PCR analysis. As
shown in Figure 4A, the mRNA level of MMP-2 increased
after IκBα siRNA transfection in a time-dependent manner
and reached to the highest level at 178%±4.6% (mean±SD,
n=4) in HCM cells at 72 h. Furthermore, western blot analysis
indicated that the protein level of MMP-2 also increased in a
time-dependent manner and reached up to 162%±3.7% (mean
±SD, n=3) compared to those in control 72 h after IκBα siRNA
transfection,  which  was  demonstrated  by  densitometry
analysis (Figure 4B). Apart from studying mRNA and protein
levels,  we  also  performed  a  functional  assay.  Two  major
gelatinolytic  activities,  which  corresponded  to  the  pro-
MMP-2 form (72 kDa) and active-MMP-2 form (66 kDa),
were observed on a gelatin zymogram assay. IκBα siRNA
transfection  increased  the  levels  of  both  pro-  and  active-
MMP-2  in  HCM  cells  in  a  time-dependent  manner  when
compared with nonsense control siRNA (NC) and control
cells after IκBα siRNA transfection. Densitometry analysis
indicated that the maximum increases achieved for both pro-
and active-MMP-2 were 172%±15% and 151%±14% (mean
±SD, n=3), respectively (Figure 4C).
Effects of IκBα siRNA on TIMP-2 and MT1-MMP expression
in HCM cells: The TIMP-2 mRNA level was suppressed at
each time point to 33.7%±6.7% at 24h, 41.7%±13.6 at 48 h
and %70.3%±13.1% (mean±SD, n=4) at 72 h, respectively,
compared to those in control after IκBα siRNA transfection
(Figure 5A). Furthermore, western blot analysis indicated the
TIMP-2 protein level in the IκBα siRNA-treated cells was
reduced significantly to 62.9%±0.8% compared to those in
control at 72 h after IκBα siRNA transfection (Figure 5B). As
shown in Figure 5C, the mRNA level of MT1-MMP increased
in a time-dependent manner and reached to the highest level
72 h after IκBα siRNA transfection at 165%±8.18% (mean ±
SD, n=4) in HCM cells. Furthermore, western blot analysis
indicated that the protein level of MT1-MMP also increased
in a time dependent manner to 135.2%±3.7% at 24h, 137.1%
±3.2% at 48h and 157.6%±5.7% (mean±SD, n=3) at 72 h,
respectively, compared to those in control after IκBα siRNA
transfection, which was demonstrated by the densitometric
analysis (Figure 5D).
Effect of IκBα siRNA on NF-κBp65 expression and nuclear
translocation  in  HCM  cells:  To  further  investigate  the
molecular mechanism that explains how the knockdown of
IκBα affects the secretion and activation of MMP-2, the NF-
κB,  which  is  in  the  downstream  pathway  of  IκBα,  was
examined in HCM cells. Real-time RT–PCR and western blot
analysis indicated that there were no significant differences
between NF-κBp65 mRNA and protein levels at each time
point  (Figure  6A,C).  Nevertheless,  the  expression  of  NF-
κBp65 in the nucleus was markedly increased in HCM cells
after IκBα siRNA transfection when compared to those in the
control  cells  (Figure  6B).  Moreover,  immunofluorescent
staining demonstrated that silencing of IκBα could induce
translocation of NF-κBp65 into the nucleus. As shown in
Figure 6D, NF-κBp65 staining mainly localizes in the nucleus
24 h, 48 h, and 72 h after IκBα siRNA transfection in HCM
cells whereas little nuclear translocation of NF-κBp65 was
observed in control HCM cells.
Figure 2. Transfection efficiency of IκBα siRNA. To monitor siRNA transfection efficiency, the HCM cells were transfected with Cy3-labled
IκBα siRNA using Lipofectamine 2000 reagent, which were viewed at 24 h, 48 h, and 72 h after transfection. Cy3-labled IκBα siRNA (red)
was observed in the cytoplasm in HCM cells, and the transfection efficiency was 92% (A), 90% (B), and 91% (C) 24 h, 48 h, and 72 h after
IκBα siRNA transfection, respectively.
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1981DISCUSSION
In the current study, our results demonstrated that the IκB/NF-
κB signaling pathway was involved in the expression and
activation  of  MMP-2  in  human  ciliary  muscle  cells.
Downregulation of IκBα by siRNA resulted in significant
translocation of NF-κBp65 from the cytoplasm to the nucleus
after 24 h to 72 h. The secretion of MMP-2 increased as well
as  the  activation  from  pro-MMP-2  to  active-MMP-2.  In
addition, the expression of MT1-MMP increased while the
expression of TIMP-2 reduced both in mRNA and protein
levels.  It  is  implied  from  these  results  that  NF-κB  is  an
important transcriptional factor involved in the control of
uveoscleral  outflow  through  the  promotion  of  MMP-2
expression.
Figure 3. Examination of IκBα mRNA
and protein levels in HCM cells 24 h, 48
h,  and  72  h  after  IκBα  siRNA
transfection. A: IκBα mRNA expression
was quantified by real-time RT–PCR.
Expression levels were normalized with
GAPDH. Error bars represent standard
deviations (SD) calculated from three
parallel  experiments.  B:  Total  cell
lysates  from  HCM  cells  treated  with
IκBα siRNA, nonsense control siRNA
(NC),  and  control  were  analyzed  by
western  blot  with  IκBα  antibody  and
GAPDH antibody. The arrows indicate
IκBα (39 kDa) and GAPDH (36 kDa)
bands.  The  bands  were  analyzed
densitometrically, and the values were
normalized  with  GAPDH,  which  are
represented in the bar graph. The mRNA
and  protein  values  of  IκBα  siRNA,
control,  and  nonsense  control  siRNA
(NC) groups were determined by one-
way  ANOVA.  The  double  asterisk
denotes p<0.01.
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1982It has been reported that NF-κB is involved in various
activities and plays a key role in multiple biological processes
including chemical stress, physical stress, physiologic stress,
receptor ligands, proinflammatory cytokines, and apoptosis.
At the same time, there are also multiple and complex signal
transduction pathways leading to NF-κB activation. However,
many of these activations are primarily performed by the so-
called classical pathway, which involves the degradation of
IκBα, leading to the release of the NF-κB complex, which in
turn allows it to relocate to the nucleus [29]. Meanwhile,
mounting  evidence  shows  that  the  IκB/NF-κB  classical
pathway is involved in the expression of MMP-2. Han et al.
[21] reported that TNF-α induced the breakdown of IκB in
fibroblasts within the collagen lattice, which is a critical step
leading to the activation of pro-MMP-2 by NF-κB. Philip and
Kundu [22] showed that osteopontin could induce NF-κB
activity through phosphorylation and degradation of IκBα by
activating I-Kappa B Kinase (IKK), which ultimately triggers
the activation of pro-MMP-2 in B16F10 cells. Park and his
colleagues [23] indicated that propylene glycol monomethyl
acetic  ether  (PMA)  treatment  resulted  in  IκBα
phosphorylation  in  fibrosarcoma  cells,  which  enhances
MMP-2  production  through  the  activation  of  NF-κB
transcription factors.
To  further  investigate  the  potential  role  of  NF-κB  in
uveoscleral  outflow,  the  expression  of  IκBα  was
downregulated by specific siRNA. We found not only the
translocation  of  NF-κBp65  from  the  cytoplasm  into  the
nucleus  but  also  the  enhanced  secretion  and  activity  of
MMP-2 after IκBα knockdown. Most MMPs are secreted in
their  inactive  pro-form  from  cells  and  in  the  active-form
outside  the  cells.  Many  studies  have  indicated  that  the
Figure 4. Effect of ablation of IκBα on
MMP-2 expression and activity 24 h, 48
h,  and  72  h  after  IκBα  siRNA
transfection.  A:  MMP-2  mRNA
expression  in  in  HCM  cells  of  IκBα
siRNA  transfected,  nonsense  control
siRNA  (NC)  transfected,  and  control
was  quantified  by  real-time  RT-PCR.
Expression levels were normalized with
GAPDH.  B:  After  IκBα  siRNA
transfection,  the  conditioned  media
were  collected  at  the  indicated  time,
concentrated, and analyzed by western
blot with MMP-2 antibody. The arrow
indicates  MMP-2  bands  that  are
analyzed by densitometry and the values
were represented in the bar graph. C:
The activity of MMP-2 is analyzed by
gelatin  zymography  analysis.  The
arrows  indicate  pro-MMP-2  (72-kDa)
and  active  MMP-2  (66-kDa)  specific
bands.  The  bands  were  analyzed  by
densitometry and are represented in the
bar  graph.  The  mRNA,  protein,  and
activity  values  of  IκBα  siRNA
transfected,  nonsense  control  siRNA
(NC)  transfected,  and  control  were
determined by one-way ANOVA. An
asterisk denotes p<0.05, and a double
asterisk indicates p<0.01.
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1983secretion [30] and activation of MMP-2 [21,22] are associated
with NF-κB . On the other hand, NF-κB signaling has also
been demonstrated to participate in the regulation of MMP-2
at a transcriptional level as shown in our study, indicating that
MMP-2 mRNA increases after NF-κB has been activated. It
has been reported that PGF2α induces c-Fos in human ciliary
smooth  muscle  cells  [31]  and  that  c-Fos  is  capable  of
physically  interacting  with  NF-κBp65  through  the  Rel
homology domain, enhancing its DNA binding and biological
function [32]. Moreover, although there is no NF-κB-binding
site  on  the  MMP-2  promoter,  it  has  been  suggested  that
MMP-2 activation occurs in endothelial cells through an NF-
κB-dependent  pathway  [30].  Apparently,  the  molecular
mechanism driving the effect of NF-κB on MMP-2 needs to
be further investigated.
In this study, downregulation of IκBα resulted in the
decrease of TIMP-2 and the increase of MT1-MMP. TIMP-2
has  been  found  to  exhibit  several  biochemical  and
physiologic/biological  functions  including  inhibition  of
active MMPs, pro-MMP activation, and so on. The balance
between TIMP-2 and MMP-2 levels is critical in determining
the activation status of MMP-2. Along with the results of
Figure 4, we found that TIMP-2 expression was reduced while
MMP-2  activation  was  enhanced  after  IκBα  siRNA
transfection in HCM cells. In addition, activation of MMP-2
also requires its cell surface localization and cleavage by cell
membrane-bound MT1-MMP, the increased expression of
MT1-MMP  promoted  the  MMP-2  expression.  The  results
showed  that  increased  pro-MMP-2  activation  reflected
upregulation of MT1-MMP expression in the IκBα siRNA
treated cells. In a word, the number of function attributed to
being  regulated  by  the  transcription  factor,  NF-κBp65,  is
rapidly increasing. We observed that translocation of NF-
κBp65 into the nucleus correlates with the decrease of TIMP-2
and the increase of MT1-MMP. Moreover, the activated NF-
κB  induced  the  secretion  and  activation  of  MMP-2.  This
evidence indicated that the expression of MMP-2 is mediated
by the activation of NF-κB and that the IκB/NF-κB signaling
pathway plays a significant role in this process.
As generally recognized, Rel/NF-κB transcription factors
appear  to  mediate  survival  signals  that  protect  cells  from
apoptosis, which may result in the development of several
tumors. It has also become clear that MMPs not only play a
role in ECM modification but they also have effects on tumor
Figure 5. Effect of knockdown IκBα on
TIMP-2 and MT1-MMP expression in
HCM cells 24 h, 48 h, and 72 h after
IκBα siRNA transfection. TIMP-2 (A)
and MT1-MMP (C) mRNA expression
in  HCM  cells  of  IκBα  siRNA
transfected,  nonsense  control  siRNA
(NC)  transfected,  and  control  was
quantified  by  real-time  RT-PCR.
Expression levels were normalized with
GAPDH.  B:  After  IκBα  siRNA
transfection,  the  conditioned  media
were  collected  at  the  indicated  time,
concentrated, and analyzed by western
blot with TIMP-2 antibody. The arrow
indicates TIMP-2 (21 kDa). The bands
were  analyzed  by  densitometry  and
represented in the bar graph. D: Total
cell lysates from HCM cells transfected
with  IκBα  siRNA  ,  nonsense  control
siRNA (NC) as well as from the control,
respectively, were analyzed by western
blot  with  MT1-MMP  antibody.  The
arrows show MT1-MMP (66 kDa) and
internal control, GAPDH (36 kDa). The
bands were analyzed by densitometry
and represented in the bar graph. The
mRNA, protein, and activity values of
IκBα  siRNA  transfected,  nonsense
control  siRNA  (NC)  transfected,  and
control  were  determined  by  one-way
ANOVA. An asterisk denotes p<0.05,
and a double asterisk indicates p<0.01.
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1984cell adhesion and motility. In our study, the activated NF-κB
and consequently, enhanced MMP-2 most likely exert an anti-
apoptotic action, promoting the survival of defective cells,
thereby causing tumor growth in HCM cells. However, not all
reports  support  a  survival  role  for  Rel/NF-κB  factors.
Experiments by Grimm et al. [33] indicated that a dominant-
negative  RelA  mutant  prevented  the  cell  death  that  was
induced upon serum starvation of 293 cells. Jung et al. [34]
reported  that  radiation-induced  apoptosis  of  ataxia
telangiectasia (AT) fibroblasts was found to be reduced by a
transdominant-negative IκBα protein. Kasibhatla et al. [35]
found that inhibition of NF-κB activity in a T cell hybridoma
leads  to  decreased  apoptosis  in  T  cells.  We  have  also
discovered a few studies reporting the detrimental effects of
MMP-2 on HCM cells. Therefore, we intend to shift our
experimentation from a predominantly in vitro system to an
animal model to further explore the role of the IκB/NF-κB
signaling pathway.
In  summary,  we  demonstrated  that  the  IκB/NF-κB
signaling pathway plays an important role in the expression
of MMP-2 in HCM cells. It is possible that the mechanism
underlying  the  uveoscleral  outflow  pathway  involves  the
Figure 6. Effect of knockdown IκBα on
the expression and cellular localization
of NF-κBp65 in HCM cells 24 h, 48 h,
and 72 h after IκBα siRNA transfection.
A:  NF-κBp65  mRNA  expression  in
HCM cells of IκBα siRNA transfected,
nonsense  control  siRNA  (NC)
transfected, and control was quantified
by real-time RT-PCR. Expression levels
were  normalized  with  GAPDH.  B:
Nuclear proteins extracted from IκBα
siRNA, nonsense control siRNA (NC),
as  well  as  control  cells,  respectively,
were analyzed by western blot with NF-
κBp65  antibody.  The  arrow  indicates
the  NF-κBp65  (75  kDa)  band  and
nucleus  internal  control,  Lamin  B
(67  kDa).  The  bands  were  analyzed
densitometrically, and the values were
normalized with Lamin B, represented
in bar graph. C: Total cell lysates from
HCM  cells  transfected  with  IκBα
siRNA,  and  nonsense  control  siRNA
(NC)  as  well  as  from  the  control,
respectively, were analyzed by western
blot  with  NF-κBp65  antibody.  The
arrows show the NF-κBp65 (75 kDa)
band and the internal control, GAPDH
(36 kDa). The mRNA and protein values
compared to the control and nonsense
control siRNA (NC) were determined
by  one-way  ANOVA.  The  double
asterisk denotes p<0.01. D: The HCM
cells  were  immunostained  with  NF-
κBp65  antibody  and  analyzed  by
fluorescence  microscopy.  A  weak
nuclear signal of NF-κBp65 (green) was
observed in control cells at 24 h, 48 h,
and  72  h.  After  IκBα  siRNA
transfection,  NF-κBp65  translocated
from the cytoplasm into the nucleus, and
a  strong  signal  of  NF-κBp65  was
detected in the nucleus at 24 h, 48 h, and
72 h. Cy3 labled IκBα siRNA (red) was
observed in the cytoplasm. Cell nuclei
were counterstained with DAPI (blue).
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1985inhibition of IκBα, leading to the activation of NF-κB p65,
which in turn, results in the increase of secretion and activity
of MMP-2. This molecular mechanism may provide a novel
insight in the development of a new strategy for the treatment
of glaucoma.
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